世界の神経因性疼痛治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Neuropathic Pain Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4095
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、神経因性疼痛治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（三環系抗うつ薬・抗けいれん薬、セロトニン・ノルエピネフリン再取り込み阻害薬、カプサイシンクリーム、局所麻酔薬、オピオイド、ステロイド、その他）、用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・神経因性疼痛治療薬の市場動向
・企業の競争状況、市場シェア
・神経因性疼痛治療薬の種類別市場規模（三環系抗うつ薬・抗けいれん薬、セロトニン・ノルエピネフリン再取り込み阻害薬、カプサイシンクリーム、局所麻酔薬、オピオイド、ステロイド、その他）
・神経因性疼痛治療薬の用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）
・神経因性疼痛治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・神経因性疼痛治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・神経因性疼痛治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・神経因性疼痛治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・神経因性疼痛治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Johnson & Johnson、Sanofi、GlaxoSmithKline、Eli Lilly、Bristol-Myers Squibb、Biogen、Baxter Healthcare、Depomed）
・結論

Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia).
In terms of value, North America is a large market and is expected to increase at over 5% CAGR during the forecast period. The Asia Pacific neuropathic pain management market is projected to show fast growth and it is projected grow at CAGR of 6% over the forecast period due to increasing prevalence of diabetes in Asia Pacific, particularly in China and India.

Market Analysis and Insights: Global Neuropathic Pain Drugs Market
The global Neuropathic Pain Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neuropathic Pain Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neuropathic Pain Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neuropathic Pain Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neuropathic Pain Drugs market.

Global Neuropathic Pain Drugs Scope and Market Size
Neuropathic Pain Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neuropathic Pain Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tricyclic Anti-Depressants Anticonvulsants
Serotonin-Norepinephrine Reuptake Inhibitor
Capsaicin Cream
Local Anaesthesia
Opioids
Steroids
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Johnson & Johnson
Sanofi
GlaxoSmithKline
Eli Lilly
Bristol-Myers Squibb
Biogen
Baxter Healthcare
Depomed

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuropathic Pain Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tricyclic Anti-Depressants Anticonvulsants
1.2.3 Serotonin-Norepinephrine Reuptake Inhibitor
1.2.4 Capsaicin Cream
1.2.5 Local Anaesthesia
1.2.6 Opioids
1.2.7 Steroids
1.2.8 Others
1.3 Market by Application
1.3.1 Global Neuropathic Pain Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Neuropathic Pain Drugs Market Perspective (2016-2027)
2.2 Neuropathic Pain Drugs Growth Trends by Regions
2.2.1 Neuropathic Pain Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neuropathic Pain Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Neuropathic Pain Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Neuropathic Pain Drugs Industry Dynamic
2.3.1 Neuropathic Pain Drugs Market Trends
2.3.2 Neuropathic Pain Drugs Market Drivers
2.3.3 Neuropathic Pain Drugs Market Challenges
2.3.4 Neuropathic Pain Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Neuropathic Pain Drugs Players by Revenue
3.1.1 Global Top Neuropathic Pain Drugs Players by Revenue (2016-2021)
3.1.2 Global Neuropathic Pain Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Neuropathic Pain Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neuropathic Pain Drugs Revenue
3.4 Global Neuropathic Pain Drugs Market Concentration Ratio
3.4.1 Global Neuropathic Pain Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuropathic Pain Drugs Revenue in 2020
3.5 Neuropathic Pain Drugs Key Players Head office and Area Served
3.6 Key Players Neuropathic Pain Drugs Product Solution and Service
3.7 Date of Enter into Neuropathic Pain Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Neuropathic Pain Drugs Breakdown Data by Type
4.1 Global Neuropathic Pain Drugs Historic Market Size by Type (2016-2021)
4.2 Global Neuropathic Pain Drugs Forecasted Market Size by Type (2022-2027)

5 Neuropathic Pain Drugs Breakdown Data by Application
5.1 Global Neuropathic Pain Drugs Historic Market Size by Application (2016-2021)
5.2 Global Neuropathic Pain Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Neuropathic Pain Drugs Market Size (2016-2027)
6.2 North America Neuropathic Pain Drugs Market Size by Type
6.2.1 North America Neuropathic Pain Drugs Market Size by Type (2016-2021)
6.2.2 North America Neuropathic Pain Drugs Market Size by Type (2022-2027)
6.2.3 North America Neuropathic Pain Drugs Market Size by Type (2016-2027)
6.3 North America Neuropathic Pain Drugs Market Size by Application
6.3.1 North America Neuropathic Pain Drugs Market Size by Application (2016-2021)
6.3.2 North America Neuropathic Pain Drugs Market Size by Application (2022-2027)
6.3.3 North America Neuropathic Pain Drugs Market Size by Application (2016-2027)
6.4 North America Neuropathic Pain Drugs Market Size by Country
6.4.1 North America Neuropathic Pain Drugs Market Size by Country (2016-2021)
6.4.2 North America Neuropathic Pain Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Neuropathic Pain Drugs Market Size (2016-2027)
7.2 Europe Neuropathic Pain Drugs Market Size by Type
7.2.1 Europe Neuropathic Pain Drugs Market Size by Type (2016-2021)
7.2.2 Europe Neuropathic Pain Drugs Market Size by Type (2022-2027)
7.2.3 Europe Neuropathic Pain Drugs Market Size by Type (2016-2027)
7.3 Europe Neuropathic Pain Drugs Market Size by Application
7.3.1 Europe Neuropathic Pain Drugs Market Size by Application (2016-2021)
7.3.2 Europe Neuropathic Pain Drugs Market Size by Application (2022-2027)
7.3.3 Europe Neuropathic Pain Drugs Market Size by Application (2016-2027)
7.4 Europe Neuropathic Pain Drugs Market Size by Country
7.4.1 Europe Neuropathic Pain Drugs Market Size by Country (2016-2021)
7.4.2 Europe Neuropathic Pain Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Neuropathic Pain Drugs Market Size (2016-2027)
8.2 Asia-Pacific Neuropathic Pain Drugs Market Size by Type
8.2.1 Asia-Pacific Neuropathic Pain Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neuropathic Pain Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neuropathic Pain Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Neuropathic Pain Drugs Market Size by Application
8.3.1 Asia-Pacific Neuropathic Pain Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neuropathic Pain Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neuropathic Pain Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Neuropathic Pain Drugs Market Size by Region
8.4.1 Asia-Pacific Neuropathic Pain Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neuropathic Pain Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Neuropathic Pain Drugs Market Size (2016-2027)
9.2 Latin America Neuropathic Pain Drugs Market Size by Type
9.2.1 Latin America Neuropathic Pain Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Neuropathic Pain Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Neuropathic Pain Drugs Market Size by Type (2016-2027)
9.3 Latin America Neuropathic Pain Drugs Market Size by Application
9.3.1 Latin America Neuropathic Pain Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Neuropathic Pain Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Neuropathic Pain Drugs Market Size by Application (2016-2027)
9.4 Latin America Neuropathic Pain Drugs Market Size by Country
9.4.1 Latin America Neuropathic Pain Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Neuropathic Pain Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Neuropathic Pain Drugs Market Size (2016-2027)
10.2 Middle East & Africa Neuropathic Pain Drugs Market Size by Type
10.2.1 Middle East & Africa Neuropathic Pain Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neuropathic Pain Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neuropathic Pain Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Neuropathic Pain Drugs Market Size by Application
10.3.1 Middle East & Africa Neuropathic Pain Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neuropathic Pain Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neuropathic Pain Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Neuropathic Pain Drugs Market Size by Country
10.4.1 Middle East & Africa Neuropathic Pain Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neuropathic Pain Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Neuropathic Pain Drugs Introduction
11.1.4 Pfizer Revenue in Neuropathic Pain Drugs Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Neuropathic Pain Drugs Introduction
11.2.4 Johnson & Johnson Revenue in Neuropathic Pain Drugs Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Neuropathic Pain Drugs Introduction
11.3.4 Sanofi Revenue in Neuropathic Pain Drugs Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Neuropathic Pain Drugs Introduction
11.4.4 GlaxoSmithKline Revenue in Neuropathic Pain Drugs Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Neuropathic Pain Drugs Introduction
11.5.4 Eli Lilly Revenue in Neuropathic Pain Drugs Business (2016-2021)
11.5.5 Eli Lilly Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Neuropathic Pain Drugs Introduction
11.6.4 Bristol-Myers Squibb Revenue in Neuropathic Pain Drugs Business (2016-2021)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Biogen
11.7.1 Biogen Company Details
11.7.2 Biogen Business Overview
11.7.3 Biogen Neuropathic Pain Drugs Introduction
11.7.4 Biogen Revenue in Neuropathic Pain Drugs Business (2016-2021)
11.7.5 Biogen Recent Development
11.8 Baxter Healthcare
11.8.1 Baxter Healthcare Company Details
11.8.2 Baxter Healthcare Business Overview
11.8.3 Baxter Healthcare Neuropathic Pain Drugs Introduction
11.8.4 Baxter Healthcare Revenue in Neuropathic Pain Drugs Business (2016-2021)
11.8.5 Baxter Healthcare Recent Development
11.9 Depomed
11.9.1 Depomed Company Details
11.9.2 Depomed Business Overview
11.9.3 Depomed Neuropathic Pain Drugs Introduction
11.9.4 Depomed Revenue in Neuropathic Pain Drugs Business (2016-2021)
11.9.5 Depomed Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Neuropathic Pain Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tricyclic Anti-Depressants Anticonvulsants
Table 3. Key Players of Serotonin-Norepinephrine Reuptake Inhibitor
Table 4. Key Players of Capsaicin Cream
Table 5. Key Players of Local Anaesthesia
Table 6. Key Players of Opioids
Table 7. Key Players of Steroids
Table 8. Key Players of Others
Table 9. Global Neuropathic Pain Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Neuropathic Pain Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Neuropathic Pain Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Neuropathic Pain Drugs Market Share by Regions (2016-2021)
Table 13. Global Neuropathic Pain Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Neuropathic Pain Drugs Market Share by Regions (2022-2027)
Table 15. Neuropathic Pain Drugs Market Trends
Table 16. Neuropathic Pain Drugs Market Drivers
Table 17. Neuropathic Pain Drugs Market Challenges
Table 18. Neuropathic Pain Drugs Market Restraints
Table 19. Global Neuropathic Pain Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Neuropathic Pain Drugs Market Share by Players (2016-2021)
Table 21. Global Top Neuropathic Pain Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropathic Pain Drugs as of 2020)
Table 22. Ranking of Global Top Neuropathic Pain Drugs Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Neuropathic Pain Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Neuropathic Pain Drugs Product Solution and Service
Table 26. Date of Enter into Neuropathic Pain Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Neuropathic Pain Drugs Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Neuropathic Pain Drugs Revenue Market Share by Type (2016-2021)
Table 30. Global Neuropathic Pain Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Neuropathic Pain Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Neuropathic Pain Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Neuropathic Pain Drugs Revenue Market Share by Application (2016-2021)
Table 34. Global Neuropathic Pain Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Neuropathic Pain Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Neuropathic Pain Drugs Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Neuropathic Pain Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Neuropathic Pain Drugs Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Neuropathic Pain Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Neuropathic Pain Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Neuropathic Pain Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Neuropathic Pain Drugs Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Neuropathic Pain Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Neuropathic Pain Drugs Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Neuropathic Pain Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Neuropathic Pain Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Neuropathic Pain Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Neuropathic Pain Drugs Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Neuropathic Pain Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Neuropathic Pain Drugs Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Neuropathic Pain Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Neuropathic Pain Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Neuropathic Pain Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Neuropathic Pain Drugs Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Neuropathic Pain Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Neuropathic Pain Drugs Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Neuropathic Pain Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Neuropathic Pain Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Neuropathic Pain Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Neuropathic Pain Drugs Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Neuropathic Pain Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Neuropathic Pain Drugs Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Neuropathic Pain Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Neuropathic Pain Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Neuropathic Pain Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Neuropathic Pain Drugs Product
Table 69. Pfizer Revenue in Neuropathic Pain Drugs Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Neuropathic Pain Drugs Product
Table 74. Johnson & Johnson Revenue in Neuropathic Pain Drugs Business (2016-2021) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Sanofi Company Details
Table 77. Sanofi Business Overview
Table 78. Sanofi Neuropathic Pain Drugs Product
Table 79. Sanofi Revenue in Neuropathic Pain Drugs Business (2016-2021) & (US$ Million)
Table 80. Sanofi Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Neuropathic Pain Drugs Product
Table 84. GlaxoSmithKline Revenue in Neuropathic Pain Drugs Business (2016-2021) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Eli Lilly Company Details
Table 87. Eli Lilly Business Overview
Table 88. Eli Lilly Neuropathic Pain Drugs Product
Table 89. Eli Lilly Revenue in Neuropathic Pain Drugs Business (2016-2021) & (US$ Million)
Table 90. Eli Lilly Recent Development
Table 91. Bristol-Myers Squibb Company Details
Table 92. Bristol-Myers Squibb Business Overview
Table 93. Bristol-Myers Squibb Neuropathic Pain Drugs Product
Table 94. Bristol-Myers Squibb Revenue in Neuropathic Pain Drugs Business (2016-2021) & (US$ Million)
Table 95. Bristol-Myers Squibb Recent Development
Table 96. Biogen Company Details
Table 97. Biogen Business Overview
Table 98. Biogen Neuropathic Pain Drugs Product
Table 99. Biogen Revenue in Neuropathic Pain Drugs Business (2016-2021) & (US$ Million)
Table 100. Biogen Recent Development
Table 101. Baxter Healthcare Company Details
Table 102. Baxter Healthcare Business Overview
Table 103. Baxter Healthcare Revenue in Neuropathic Pain Drugs Business (2016-2021) & (US$ Million)
Table 104. Baxter Healthcare Recent Development
Table 105. Depomed Company Details
Table 106. Depomed Business Overview
Table 107. Depomed Neuropathic Pain Drugs Product
Table 108. Depomed Revenue in Neuropathic Pain Drugs Business (2016-2021) & (US$ Million)
Table 109. Depomed Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuropathic Pain Drugs Market Share by Type: 2020 VS 2027
Figure 2. Tricyclic Anti-Depressants Anticonvulsants Features
Figure 3. Serotonin-Norepinephrine Reuptake Inhibitor Features
Figure 4. Capsaicin Cream Features
Figure 5. Local Anaesthesia Features
Figure 6. Opioids Features
Figure 7. Steroids Features
Figure 8. Others Features
Figure 9. Global Neuropathic Pain Drugs Market Share by Application: 2020 VS 2027
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Neuropathic Pain Drugs Report Years Considered
Figure 14. Global Neuropathic Pain Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Neuropathic Pain Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Neuropathic Pain Drugs Market Share by Regions: 2020 VS 2027
Figure 17. Global Neuropathic Pain Drugs Market Share by Regions (2022-2027)
Figure 18. Global Neuropathic Pain Drugs Market Share by Players in 2020
Figure 19. Global Top Neuropathic Pain Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropathic Pain Drugs as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Neuropathic Pain Drugs Revenue in 2020
Figure 21. Global Neuropathic Pain Drugs Revenue Market Share by Type (2016-2021)
Figure 22. Global Neuropathic Pain Drugs Revenue Market Share by Type (2022-2027)
Figure 23. North America Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Neuropathic Pain Drugs Market Share by Type (2016-2027)
Figure 25. North America Neuropathic Pain Drugs Market Share by Application (2016-2027)
Figure 26. North America Neuropathic Pain Drugs Market Share by Country (2016-2027)
Figure 27. United States Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Neuropathic Pain Drugs Market Share by Type (2016-2027)
Figure 31. Europe Neuropathic Pain Drugs Market Share by Application (2016-2027)
Figure 32. Europe Neuropathic Pain Drugs Market Share by Country (2016-2027)
Figure 33. Germany Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Neuropathic Pain Drugs Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Neuropathic Pain Drugs Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Neuropathic Pain Drugs Market Share by Region (2016-2027)
Figure 43. China Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Neuropathic Pain Drugs Market Share by Type (2016-2027)
Figure 51. Latin America Neuropathic Pain Drugs Market Share by Application (2016-2027)
Figure 52. Latin America Neuropathic Pain Drugs Market Share by Country (2016-2027)
Figure 53. Mexico Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Neuropathic Pain Drugs Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Neuropathic Pain Drugs Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Neuropathic Pain Drugs Market Share by Country (2016-2027)
Figure 59. Turkey Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Neuropathic Pain Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Pfizer Revenue Growth Rate in Neuropathic Pain Drugs Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Neuropathic Pain Drugs Business (2016-2021)
Figure 64. Sanofi Revenue Growth Rate in Neuropathic Pain Drugs Business (2016-2021)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Neuropathic Pain Drugs Business (2016-2021)
Figure 66. Eli Lilly Revenue Growth Rate in Neuropathic Pain Drugs Business (2016-2021)
Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Neuropathic Pain Drugs Business (2016-2021)
Figure 68. Biogen Revenue Growth Rate in Neuropathic Pain Drugs Business (2016-2021)
Figure 69. Baxter Healthcare Revenue Growth Rate in Neuropathic Pain Drugs Business (2016-2021)
Figure 70. Depomed Revenue Growth Rate in Neuropathic Pain Drugs Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の疼痛管理治療薬市場規模・現状・予測（2021年-2027年）

Global Pain Management Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z4406 2021年4月 132Pages
QYResearch社発行の本調査資料では、疼痛管理治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ジェネリックオピオイド、ブランドオピオイド、NSAID、その他）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米...

世界の疼痛管理治療薬市場規模・現状・予測（2021年-2027年）

世界のペット用痛み管理薬市場規模・現状・予測（2021年-2027年）

Global Pet Pain Management Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z4547 2021年4月 90Pages
QYResearch社発行の本調査資料では、ペット用痛み管理薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（NSAID、オピオイド、局所麻酔薬、アルファ2アゴニスト、変形性膝関節症治療薬、その他）、用途別市場規模（犬、猫、馬、その他）、主要地...

世界の変形性関節症鎮痛剤市場規模・現状・予測（2021年-2027年）

Global Drugs for Osteoarthritis Pain Market Size, Status and Forecast 2021-2027
QYR2104Z2002 2021年4月 128Pages
QYResearch社発行の本調査資料では、変形性関節症鎮痛剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射、外部）、用途別市場規模（医療、パーソナルケア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、...

世界の術後疼痛管理市場規模・現状・予測（2021年-2027年）

Global Post-operative Pain Management Market Size, Status and Forecast 2021-2027
QYR2104Z4711 2021年4月 94Pages
QYResearch社発行の本調査資料では、術後疼痛管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬、オピオイド、その他）、用途別市場規模（がん、関節炎、神経障害性、筋骨格痛、片頭痛）、主要地域別市場規模（北米、アメリ...

世界の疼痛管理治療薬市場規模・現状・予測（2021年-2027年）

Global Pain Management Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z4408 2021年4月 99Pages
QYResearch社発行の本調査資料では、疼痛管理治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗けいれん薬、抗うつ薬、麻酔薬、非ステロイド性抗炎症薬（NSAID）、オピオイド、抗片頭痛薬、その他）、用途別市場規模（神経障害性疼痛、線...

世界の疼痛管理市場規模・現状・予測（2021年-2027年）

Global Pain Management Market Size, Status and Forecast 2021-2027
QYR2104Z4407 2021年4月 91Pages
QYResearch社発行の本調査資料では、疼痛管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、機器）、用途別市場規模（やけど、癌性、歯科/顔面、片頭痛、筋骨格、神経障害性、産科）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の慢性膵炎疼痛市場規模・現状・予測（2021年-2027年）

Global Chronic Pancreatitis Pain Market Size, Status and Forecast 2021-2027
QYR2104Z1327 2021年4月 94Pages
QYResearch社発行の本調査資料では、慢性膵炎疼痛のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、治療用研究）、用途別市場規模（薬物療法、手術療法、内視鏡療法）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、...

世界の内臓痛市場規模・現状・予測（2021年-2027年）

Global Visceral Pain Market Size, Status and Forecast 2021-2027
QYR2104Z5950 2021年4月 91Pages
QYResearch社発行の本調査資料では、内臓痛のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛剤、疼痛修飾剤）、用途別市場規模（間質性膀胱炎、クローン病、過敏性腸症候群、慢性前立腺炎）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の膝痛管理市場規模・現状・予測（2021年-2027年）

Global Knee Pain Management Market Size, Status and Forecast 2021-2027
QYR2104Z3331 2021年4月 91Pages
QYResearch社発行の本調査資料では、膝痛管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（急性膝痛、慢性膝痛）、用途別市場規模（病院薬局、小売薬局、ドラッグストア、Eコマース、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、...

世界のペット用痛み管理薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pet Pain Management Drugs Market The global Pet Pain Management Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…
世界の疼痛管理治療薬市場規模・現状・予測（2021年-2027年） Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2…
世界の疼痛管理治療薬市場規模・現状・予測（2021年-2027年） Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2…
世界の術後疼痛管理市場規模・現状・予測（2021年-2027年） Postoperative pain management aims to minimise patient discomfort, facilitate early mobilization and functional recovery, and prevent acute pain developing into chronic pain. Mental health can affect a patient’s recovery and psychological vulnerability is predictive of severe postoperative pain. Edu…
世界のペット用疼痛管理薬市場 2021：企業別、地域別、種類・用途別 The Pet Pain Management Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…